Abstract
Purpose. A series of derivatives having a propranolol-like moiety linked to NO-donor furoxan substructures were synthesized. The main objective of this investigation was to obtain agents with mixed NO-dependent vasodilating and β-blocking activities.
Methods. Most of the target compounds were synthesized from the appropriate furoxans bearing XCH2CH2NH2 (X = O, S, SO2) chains at the 4 position of the ring, using A1(C2H5)3 in methylene chloride solution and (±)2,3-epoxypropyl 1-naphtyl ether. Two of the final products (X = CONH) were obtained by coupling the appropriate furoxancarboxylic acids with N-[2-hydroxy-3-(l-naphthoxy)propyl]-ethylenediamine. β1- and β2-blocking activities were examined on isolated guinea pig right atria and on guinea pig trachea respectively. Vasodilating properties were assessed on endothelium denuded strips of rat aorta.
Results. Some derivatives behave as well balanced 'hybrids' displaying NO-dependent vasodilating and β-blocking properties in the same concentration range. Some others display either prevalent β-blocking or vasodilating activity. Generally speaking hybrid formation lowers the affinity for β-receptors, in particular for β2-type, to give an increase in β1/β2 selectivity.
Conclusions. The furoxan system is a flexible tool in designing analogues of propranolol whose NO-donating and β-blocking properties are modulated over a wide range.
Similar content being viewed by others
REFERENCES
B. J. R. Nicolaus. Symbiotic Approach to Drug Design. In Decision Making in Drug Research; Gross, F. Ed.; Raven Press: New York, 1983; pp 173–186.
a)P. A. Van Zwieten. J. Hypertens. 8:687–696 (1990); b) P. A. Van Zwieten. Drugs. 45:509–517 (1993).
J. A. M. Christiaans and H. Timmerman. Eur. J. Phar. Sci. 4:1–22 (1996).
J. F. Kerwin, Jr., J. R. Lancaster, Jr., and P. L. Feldman. J. Med. Chem. 38:4343–4362 (1995).
A. Gasco, R. Fruttero, and G. Sorba. Il Farmaco 51:617–635 (1996).
D. Ghigo, R. Heller, R. Calvino, P. Alessio, R. Fruttero, A. Gasco, A. Bosia, and G. Pescarmona. Biochem. Pharmacol. 43:1281–1288 (1992).
M. Feelish, K. Schönafinger, and E. Noack. Biochem. Pharmacol. 44:1149–1157 (1992).
R. Ferioli, G. C. Folco, C. Ferretti, A. M. Gasco, C. Medana, R. Fruttero, M. Civelli, and A. Gasco. Br. J. Pharmacol. 114:816–820 (1995).
A. Di Stilo, C. Cena, A. M. Gasco, A. Gasco, D. Ghigo, and A. Bosia. Bioorg. Med. Chem. Lett. 6:2607–2612 (1997).
M. Hecker, W. Vorhoff, A. T. Bara, P. I. Mordvintcev, and R. Busse. Nauny-Schmiedeberg's Arch. Pharmacol. 351:426–432 (1995).
C. Medana, G. Ermondi, R. Fruttero, A. Di Stilo, C. Ferretti, and A. Gasco. J. Med. Chem. 37:4412–4416 (1994).
G. Sorba, C. Medana, R. Fruttero, C. Cena, A. Di Stilo, U. Galli, and A. Gasco. J. Med. Chem. 40:463–469 (1997).
H. Bohn, J. Brendel, P. A. Martorana, and K. Schönafinger. Br. J. Pharmacol. 114:1605–1612 (1995).
R. Fruttero, D. Boschi, A. Di Stilo and A. Gasco. J. Med. Chem. 38:4944–4949 (1995).
B. G. Main, β-Adrenergic Receptors. In Comprehensive Medicinal Chemistry. Hansch, C. Ed; Pergamon Press, Oxford, 1990. Vol 3, pp 188–228.
G. Sorba, G. Ermondi, R. Fruttero, U. Galli and A. Gasco. J. Heterocycl. Chem. 33:327–334 (1996).
R. Calvino, V. Mortarini, A. Gasco, A. Sanfilippo, and M. L. Ricciardi. Eur. J. Med. Chem. 15:485–487 (1980).
C. Grundman, G. W. Nickel, and R. K. Bansal. Liebigs Ann. Chem. 1029–1050 (1975).
E. R. Marle. J. Chem. Soc. 101:305–317 (1912).
A. M. Gasco, R. Fruttero, G. Sorba, and A. Gasco. Liebigs Ann. Chem. 1211–1213 (1991).
D. Atlas, M. L. Steer, and A. Levitzki. Proc. Natl. Acad. Sci. USA 73:1921–1925 (1976).
A. P. Krapto and C. S. Kuell. Synth. Comm. 20:2559–2564 (1990).
L. E. Overman and L. A. Flippin. Tetrahedron Lett. 22:195–198 (1981).
J. R. Lancaster, Jr. Proc. Natl. Acad. Sci. USA. 91:8137–8141 (1994).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Boschi, D., Di Stilo, A., Cena, C. et al. Studies on Agents with Mixed NO-Dependent Vasodilating and β-Blocking Activities. Pharm Res 14, 1750–1758 (1997). https://doi.org/10.1023/A:1012136030849
Issue Date:
DOI: https://doi.org/10.1023/A:1012136030849